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A33853, which shows excellent bioactivity against
Leishmania, is a benzoxazole-family compound
formed from two moieties of 3-hydroxyanthranilic
acid and one 3-hydroxypicolinic acid. In this study,
we have identified the gene cluster responsible for
the biosynthesis of A33853 in Streptomyces sp.
NRRL12068 through genome mining and heterolo-
gous expression. Bioinformatics analysis and func-
tional characterization of the orfs contained in the
gene cluster revealed that the biosynthesis of
A33853 is directed by a group of unusual enzymes.
In particular, BomK, annotated as a ketosynthase,
was found to catalyze the amide bond formation be-
tween 3-hydroxypicolinic and 3-hydroxyanthranilic
acid during the assembly of A33853. BomJ, a puta-
tive ATP-dependent coenzyme A ligase, and BomN,
a putative amidohydrolase, were further proposed
to be involved in the benzoxazole formation in
A33853 according to gene deletion experiments.
Finally, we have successfully utilized mutasynthesis
to generate two analogs of A33853, which were re-
ported previously to possess excellent anti-leish-
manial activity.
INTRODUCTION
Leishmaniasis is one of the most neglected tropical diseases
caused by several protozoan parasites belonging to the genus
Leishmania, which are transmitted to humans through the bites
of infected female sandflies. Leishmaniasis is currently prevalent
in 98 countries, where 1.3 million new cases and 20,000 to
40,000 deaths are estimated to occur each year (Alvar et al.,
2012). Moreover, about 350million people are at risk of infection,
and 1.7 billion people live in areas suitable for leishmaniasis
transmission, which raises global health concern about this dis-
ease (Pigott et al., 2014; Salam et al., 2014).
Due to the slow rate of progress in vaccine development
against Leishmania, current leishmaniasis control mainly relies
on several non-specific drugs (Chappuis et al., 2007; Mutiso
et al., 2013). Pentavalent antimonials, which are very toxic andChemistry & Biology 22, 1313–1show serious side effects including cardiac arrhythmia and acute
pancreatitis, have been widely used as the first-line treatment for
all kinds of leishmaniasis for more than 70 years (Chappuis et al.,
2007). Recently, new anti-leishmanial agents, such as amphoter-
icin B, miltefosine, and paromomycin, have been developed to
replace antimonials gradually (Croft et al., 2006a). Despite their
much better Leishmania inhibition effects compared with anti-
monials, these drugs are still far from satisfactory because of
their high treatment cost, normal cell toxicity, side effects, and
the emergence of drug resistance (Joshi et al., 2014). Hence, it
is imperative to discover and develop new anti-leishmanial mo-
lecular scaffolds with improved bioactivity and lowered cytotox-
icity (Chappuis et al., 2007; Croft et al., 2006a, 2006b).
Antibiotic A33853 (1, Figure 1) was isolated from the culture
broth of Streptomyces sp. NRRL12068 three decades ago (Mi-
chel et al., 1984; Tipparaju et al., 2008). Early studies have shown
that 1 exhibits broad-spectrum antibiotic/antiviral activity by in-
hibiting the growth of certain pathogenic microorganisms and
a number of viruses (Michel et al., 1984). Recently, 1 has been
found to possess potent anti-leishmanial activity, 3-fold more
active than the oral drug miltefosine, which makes 1 and its an-
alogs promising scaffolds for the development of novel anti-
leishmanial drugs (Tipparaju et al., 2008).
Structurally, 1 contains an unusual benzoxazole-based scaf-
fold composed of two molecules of 3-hydroxyanthranilic acid
(3-HAA) and one unit of 3-hydroxypicolinic acid (3-HPA) (Fig-
ure 1). Several natural products including nataxazole (Sommer
et al., 2008), UK-1 (Shibata et al., 1993), caboxamycin (Hohmann
et al., 2009), and calcimycin (Reed and Lardy, 1972) also contain
the same benzoxazole moiety found in 1 (Figure 1), which raises
an interesting question of how this unusual moiety is con-
structed by nature in these compounds. In the biosynthesis of
calcimycin, 3-HAA has been demonstrated to condense with
CalA4-tethered polyketide chain to form the direct precursor
of the benzoxazole ring (Wu et al., 2011). Recently, Olano and
coworkers identified the biosynthetic pathway of nataxazole,
in which the biosynthesis of benzoxazole moiety was suggested
to follow a similar condensation reaction between NatAC1-teth-
ered 6-methylsalicylic acid (6-MSA) and NatAC2-tethered
3-HAA (Cano-Prieto et al., 2015). In both aforementioned cases,
an acetalization reaction has been proposed to be essential for
the generation of the benzoxazole ring. However, no enzyme(s)
has been characterized for this role until now, and this remains
the most important piece in the benzoxazole compounds
biosynthesis puzzle.324, October 22, 2015 ª2015 Elsevier Ltd All rights reserved 1313
Figure 1. Structures of A33853 and Other Natural Products Contain-
ing a Benzoxazole MoietyWhile 1 provides such an excellent lead for anti-leishmanial
activity, it is often essential to generate analogs with improved
physicochemical properties (Tipparaju et al., 2008). One expedi-
tious approach is through combining the harnessed biosynthetic
pathway with mutasynthesis. The biosynthesis of 1must first be
understood to achieve this.
Here, we report the identification and characterization of the
gene cluster responsible for the biosynthesis of 1 in Strepto-
myces sp. NRRL12068. Biochemical characterization of the pu-
tative ketosynthase BomK demonstrates that it catalyzed the
amide bond coupling between 3-HAA and 3-HPA. Through
gene deletion experiments, we then revealed that BomJ and
BomN, a putative ATP-dependent coenzyme A (CoA) ligase
and a putative amidohydrolase, respectively, may be involved
in the assembly of the benzoxazole ring in 1. With the disclosure
of the assembly logic of 1, we further generated two analogs of 1,
which were reported previously to possess anti-leishmanial ac-
tivity comparable with that of miltefosine, by employing the strat-
egy of mutasynthesis in DbomE mutant.RESULTS
Identification of the A33853 Biosynthetic Gene Cluster
in Streptomyces sp. NRRL12068
Based on the observation that 1 and calcimycin share the
same benzoxazole moiety (Figure 1), we speculated that the
3-HAA units in both compounds may have the same origin.
In calcimycin biosynthesis, three enzymes (encoded by
calB1 through calB3) are involved in the conversion of choris-
mate to 3-HAA via the shikimate pathway (Wu et al., 2011).
Thus, these gene products could be used as baits to identify
the A33853 biosynthetic gene cluster. To this end, Strepto-
myces sp. NRRL12068 was subjected to Illumina genome
sequencing (see Experimental Procedures). A homolog search
of CalB1-B4 in the annotated genome of Streptomyces sp.
NRRL12068 revealed a putative gene cluster encoding 4
open reading frames (ORFs) (BomO–BomR) that share high
sequence similarity to CalB1–CalB4 (Figure 2A; Table S1).
To verify the correlation of this gene cluster with A338531314 Chemistry & Biology 22, 1313–1324, October 22, 2015 ª2015 Eproduction in Streptomyces sp. NRRL12068, bomO (the ho-
mologous gene of calB3) was inactivated. High-performance
liquid chromatography (HPLC) analysis showed that the pro-
duction of 1 was completely abolished in the extract of the
bomO deletion mutant (WDY211, Figure 3), suggesting that
the identified gene cluster may be involved in the biosyn-
thesis of 1.
Heterologous Expression of the A33853 Biosynthetic
Gene Cluster in Streptomyces albus
To further determine whether the identified gene cluster is
responsible for the biosynthesis of 1, we constructed a genomic
library of Streptomyces sp. NRRL12068 using an integrative
Streptomyces-Escherichia coli shuttle vector, pJTU2554 (Li
et al., 2008). A PCR-based scanning using bomO as a probe
was performed to obtain a cosmid 8D3, which covers 35 kb
of the chromosome region spanning from orf1 to orf4 (Figure 2A).
Cosmid 8D3 was then introduced into Streptomyces albus
J1074 to generate the recombinant strain WDY200. Comparison
of the HPLC profile between the ethyl acetate extracts of
WDY200 and the control S. albus strain (WDY502, containing
an empty vector) revealed one distinct peak in the extract of
WDY200, which had the same retention time with the peak of 1
in the extract of Streptomyces sp. NRRL12068 (Figure 2B).
This peak was further characterized through high-resolution
electrospray ionization mass spectrometry (HR-ESIMS), which
gave an ion with the same mass as protonated 1 (m/z
392.0880 [M + H]+, calculated 392.0877 [M + H]+, Figure 2C).
TandemMS (MS/MS) analysis also indicated that the fragmenta-
tion pattern of the peak matches exactly that of 1 from Strepto-
myces sp. NRRL12068 (Figure 2C). Taken together, these results
demonstrate that the identified gene cluster in cosmid 8D3 is
responsible for the production of 1, and henceforth we named
this gene cluster bom.
Determination of the A33853 Gene Cluster Boundaries
To determine the minimal contiguous gene cluster required for
the biosynthesis of 1, we inactivated a series of orfs at both
sides of the region covered by cosmid 8D3 in NRRL12068
through in-frame deletion. On the left side, deletion of orf2
had no effect on the production of 1 (Figure 2B), suggesting
that this gene is located outside the bom cluster. In contrast,
deletion of bomB completely abolished the production of 1 in
the mutant strain WDY204, confirming that this gene is essen-
tial for the biosynthesis of 1 (Figure 2B). Because many efforts
to knock out bomA in Streptomyces sp. NRRL12068 failed,
we then removed bomA from the cosmid 8D3 by targeted
in-frame deletion, and introduced 8D3DbomA into S. albus
for heterologous expression. HPLC analysis of the ethyl ace-
tate extract of the recombinant strain WDY223 showed that
production of 1 was completely abolished in this strain
compared with WDY200 (Figure 2B), thus confirming that
bomA is the upstream border of the bom cluster. On the right
side, deletion of orf3 led to no change in the metabolic profile
of the resultant mutant strain WDY213, while the production
of 1 decreased in the DbomR mutant strain WDY212
compared with that in the wild-type strain (Figure 2B), indi-
cating that bomR marks the downstream border of the bom
cluster.lsevier Ltd All rights reserved
Figure 2. Identification of A33853 Biosyn-
thetic Gene Cluster
(A) Genetic organization of the A33853 biosyn-
thetic gene cluster. The deduced functions of
each gene are labeled in color and summarized in
Table S1.
(B) HPLC analysis of the heterologous expression
of 8D3 in Streptomyces albus, and determination
of the boundaries of the bom gene cluster. HPLC
analysis of the metabolites of (i) wild-type Strep-
tomyces sp. NRRL12068; (ii) S. albus::8D3 (WDY
200); (iii) S. albus::empty vector pJTU2554
(WDY502); (iv) S. albus::8D3DbomA (WDY223); (v)
DbomBmutantWDY204; (vi) orf2 in-frame deletion
mutant WDY202; (vii) DbomR mutant WDY212;
and (viii) orf3 in-frame deletion mutant WDY213.
UV monitored at 254 nm.
(C) HR-ESIMS/MS analysis of compound 1.In Silico and Functional Analysis of the Genes Involved
in A33853 Biosynthesis
Based on the sequence analysis of the deduced products of
each gene in the bom cluster (Table S1), these genes can be
classified into four groups.
Genes Putatively Involved in the Biosynthesis of 3-HAA
Four genes, bomO to bomR, are identified in the bom cluster to
encode proteins that show high similarity to those (CalB1–CalB4
and NatAL–NatDB) involved in the biosynthesis of 3-HAA moiety
in calcimycin and nataxazole pathway, respectively (Table S1)
(Cano-Prieto et al., 2015; Wu et al., 2011). The gene bomR en-
codes a putative 3-deoxy-D-arabino-heptulosonic acid 7-phos-
phate (DAHP) synthase, which may catalyze the condensation of
phosphoenolpyruvate and erythrose-4-phosphate to form
DAHP, the precursor for the following chorismate biosynthesis.
BomQ, a putative anthranilate synthase, may catalyze the addi-
tion of ammonia from glutamine to C2 of chorismate to generate
2-amino-2-desoxyisochorismate, which is further hydrolyzed
by BomP, a putative isochorismatase, to remove the vinyl
ether functional group to yield 2,3-dihydro-3-hydroxyanthranilic
acid (DHHA). The gene product of bomO is a putative 2,3-dihy-
dro-2,3-dihydroxybenzoate dehydrogenase, which is possibly
involved in the oxidation of DHHA to afford 3-HAA. TakenChemistry & Biology 22, 1313–1324, October 22, 2015 ªtogether, bomO–bomR constitute a
gene cassette responsible for the supply
of 3-HAA moiety for the assembly of 1
(Scheme 1A).
Genes Putatively Involved in the
Biosynthesis of 3-HPA
The gene product of bomE resembles the
L-lysine 2-aminotransferase VisA from
Streptomyces virginiae (63% identity),
which has been characterized in vitro to
convert L-lysine into D1–piperidine 2-car-
boxylic acid by transamination of the 2-
amino group of the substrate (Namwat
et al., 2002). To clarify its function, we
deleted the gene bomE in-frame, yielding
the DbomE mutant WDY201. HPLC anal-
ysis indicated that WDY201 completelyabolished the production of 1 but accumulated two new com-
pounds (2 and 5, Figure 3). The chemical formula of 2was deter-
mined by HR-ESIMS to be C21H15O2N5
+ (m/z 375.0969 [M + H]+,
calculated 375.0976, Figure 4A). Further MS/MS analysis of 2’s
fragmentation pattern suggested that it has the same structure
as 1, except for the 3-HPA moiety being substituted by the ben-
zoic acid (Figure 4A). The structure of 5 was revealed to differ
from 1 by lacking the 3-HPA unit through nuclear magnetic reso-
nance (NMR) analysis including 1H, 13C, correlation spectros-
copy (COSY), heteronuclear single-quantum coherence, and
heteronuclear multiple-bond correlation (HMBC) (Figures 4B
and S1). These results suggested that BomE is responsible for
the biosynthesis of 3-HPA, and other building block(s) (i.e. ben-
zoic acid) in addition to 3-HPA could also be recognized by
bom machineries and incorporated into 1’s assembly line in
the DbomEmutant. To further investigate the lysine aminotrans-
ferase activity, we expressed and purified to homogeneity the re-
combinant protein BomE from E. coli. The biochemical reactions
were monitored according to the method developed previously
(Soda et al., 1968). Liquid chromatography (LC)-MS analysis
showed that both L-lysine and D-lysine can be converted by
BomE to generate D1-piperidine 2-carboxylate, which reacted
specifically with aminobenzaldehyde (4) to give compound 3,2015 Elsevier Ltd All rights reserved 1315
Figure 3. HPLC Analysis of Metabolite Profiles of the bom Gene
In-Frame Deletion Mutants
(i) Wild-type Streptomyces sp. NRRL12068; (ii) DbomE mutant WDY201; (iii)
DbomJ mutant WDY207; (iv) DbomK mutant WDY208; (v) DbomL mutant
WDY209; (vi) DbomNmutant WDY210; (vii) DbomOmutant WDY211; and (viii)
WDY211 fed with compound 7. UV monitored at 254 nm.while no transformation of L/D-lysine took place when heat-inac-
tivated BomE was used in the control reaction (Figure S2). This
finding definitely supports the proposed pathway in Scheme
1B that lysine is the precursor for biosynthesis of 3-HPA.
There are three orfs in bom gene cluster possibly involved in
the following oxidation tailoring on D1-piperidine 2-carboxylic
acid. The gene bomB encodes a putative oxidoreductase in
the bom gene cluster, whichmight be responsible for the aroma-
tization of D1-piperidine 2-carboxylic acid to give picolinate
(Scheme 1B). One support for this hypothesis is that BomB
shares 40% sequence similarity with NikD that has been charac-
terized to catalyze an unusual four-electron oxidation reaction to
transform D1-piperideine-2-carboxylate to picolinate in the
biosynthesis of nikkomycin (Bruckner et al., 2004; Venci et al.,
2002). Moreover, as mentioned above, production of 1 was
blocked in the DbomB mutant strain WDY204. However, this
mutant could also accumulate a new compound whose identity
was confirmed to be the same as 5 (Figures 2B and 4B). These
results further support the proposed pathway directing the
biosynthesis of 3-HPA.1316 Chemistry & Biology 22, 1313–1324, October 22, 2015 ª2015 EThe gene product of bomD is a putative flavin-dependent
oxidoreductase displaying similarity with TgaE from Sorangium
cellulosum (30% identity, 45% similarity). Given that TgaE is a
functional flavin-dependent hydroxylase responsible for the
C-17 hydroxylation in the biosynthesis of Soce-thuggacin B
(Buntin et al., 2010), BomD is possibly involved in the C-3 hy-
droxylation of picolinate (Scheme 1B). The gene bomA encodes
a putative nicotinamide adenine dinucleotide (NADH):flavin
mononucleotide (FMN) oxidoreductase, which shows high
similarity to Med-orf13 (53% identity) from Streptomyces sp.
AM-7161 (Ichinose et al., 2003), SnaC (51% identity) from
Streptomyces pristinaespiralis (Blanc et al., 1995), and ActVB
(39% identity) from Streptomyces coelicolor A3(2) (Kendrew
et al., 1995). All of these proteins belong to the two-component
monooxygenase system, which is generally involved in cata-
lyzing the reduction of FMN by NADH and supplying the
reduced flavin to other monooxygenase(s) for the subsequent
oxidation of various substrates (Ellis, 2010; Sucharitakul et al.,
2014). Thus, BomA may act as the FMNH2-supplying partner
enzyme with BomD.
Interestingly, we also found a very small orf bomF, which
locates immediately downstream of bomE. BomF is a putative
tautomerase belonging to 4-oxalocrotonate tautomerase family,
members of which have been characterized to be involved in the
conversion of 2-hydroxymuconate to 2-oxo-3-heedioate in a
catabolic pathway for aromatic hydrocarbons (Burks et al.,
2010; Wang et al., 2007). The exact function of BomF in the
biosynthesis of 1 remains to be determined.
Genes Putatively Involved in the Assembly of 1
The bom cluster contains two genes, bomL and bomM, which
encode proteins with high sequence similarity to PyrA (61%
identify), a 3-HPA:AMP ligase, and PyrU (32% identity), the
phosphopantetheine-binding protein in the biosynthesis of
pyridomycin (Huang et al., 2011), respectively. The DbomL
mutant WDY209 completely lost the production of 1 but accu-
mulated a new compound with the same retention time as 5
produced by WDY201 (Figure 3). HR-ESIMS analysis of the
compound showed an [M + H]+ ion at m/z 271.0713, thus con-
firming the identity of the compound as 5 (Figure 4B). This
result suggested that activation of 3-HPA is required before
this moiety could be incorporated into the assembly line of 1.
To confirm the functions of BomL and BomM, we performed
the enzyme assays of these two proteins in vitro. The recombi-
nant BomL was then overexpressed in E. coli and purified
to homogeneity, while BomM was overexpressed in E. coli
together with Sfp to ensure the complete conversion of the
apo form of BomM to its corresponding holo form. The reaction
was set up by incubating the substrate 3-HPA with both
BomL and holo-BomM in a buffer containing Mg2+, ATP, and
DTT. HR-ESIMS analysis showed that a new peak appeared
at m/z 12268.1 Da, which corresponds to the molecular ion
for 3-HPA-BomM (calculated 12,269.1 Da) (Figure 5C), consis-
tent with the activation and transfer of 3-HPA to holo-BomM
catalyzed by BomL.
Immediately upstream of bomL is located the gene of bomK,
which encodes for a putative b-ketoacyl-acyl carrier protein
(ACP) synthase (KSIII-like protein). Enzymes in this family are
usually involved in the biosynthesis of polyketide natural prod-
ucts. To examine the function of BomK, we carried out thelsevier Ltd All rights reserved
Scheme 1. The Proposed Biosynthetic
Pathway of A33853
(A) Biosynthesis of 3-HAA.
(B) Biosynthesis of 3-HPA.
(C) Putative assembly line of A33853.in-frame deletion of bomK in Streptomyces sp. NRRL12068.
HPLC monitoring of the fermentation culture of the DbomK
mutant WDY208 showed that the formation of 1 was completely
abolished (Figure 3) and, unexpectedly, compound 5 was accu-
mulated as determined byHR-ESIMS andMS/MS fragmentation
analysis. We thus speculated that BomKmay catalyze the amide
bond formation between the amino group of the 3-HAA and the
carbonyl group of the BomM-tethered 3-HPA (Scheme 1C). To
demonstrate the exact function of BomK, the N-terminal small
ubiquitin-related modifier (SUMO)-tagged BomK was produced
in E. coli and the cell-free extract (CFE) of the recombinant E. coli
was subjected to enzyme assay in vitro. The reaction of BomL/
BomM with 3-HPA (see above) proceeded for 30 min, followed
by addition of compound 5 and BomK-CFE. Analysis by LC
coupled with HR-ESIMS observed the formation of 1 as evi-
denced by the exact mass and the same HPLC retention time
as the authentic 1 (Figure 5D). In control experiments when as-
says were conducted with the CFE of the wild-type E. coli, there
was no appearance of 1. These results clearly verified that BomK
is responsible for the amide bond formation between 3-HPA and
3-HAA during the biosynthesis of 1.
The gene bomN encodes a putative amidohydrolase. To verify
in vivo function of bomN, we constructed a mutant strain,
WDY210, in which bomN was deleted in-frame. To our surprise,
HPLC analysis indicated that WDY210 completely lost the
production of 1 but accumulated two compounds (7 and 8, Fig-
ure 3). The structure of 7 was further determined through the
interpretation of 1D and 2D NMR spectra (Figure S3). Although
8 could not be isolated, its mass is consistent with the predicted
structure of 8 as deduced from the HR-ESIMS and MS/MSChemistry & Biology 22, 1313–1324, October 22, 2015analysis (Figure 4). Both compounds lack
the oxazole moiety compared with 5
and 1, which implies that BomN may
catalyze the heterocyclization reaction to
afford the benzoxazole ring. To exclude
the possibility of whether compound 7
accumulated in WDY210 is a shunt
product, it was then fed to the fermen-
tation culture of WDY211 in which the
supply of 3-HAA is interrupted (Figure 3).
As expected, WDY211 could convert 7
into 1, 2, and 5 (Figure 3), confirming
that 7 is a true intermediate resulting
from the inactivation of bomN. Although
the catalytic mechanism of BomN still
remains enigmatic at present, these re-
sults unambiguously characterize that 7
is the direct precursor of benzoxazole
biosynthesis.
The accumulation of compound 8 in
DbomN mutant led us to speculate thatit may be generated by coupling of 7 and 3-HPA-BomM cata-
lyzed by BomK (Scheme 1C). To verify this assumption, we
incubated 7 with BomK-CFE in the assay system in the same
way as for 5. LC-HR-ESIMS clearly showed the production of
8 in the reaction sample compared with the control (Figure 5D).
These data suggest that both 5 and 7 could be recognized by
BomK. However, we cannot determine whether 8 is a shunt
product or an alternative precursor for the biosynthesis of 1
at present.
The gene product of bomJ shows high sequence similarity to
coenzyme F390 synthetase or phenylacetate-CoA ligase. En-
zymes belonging to this family usually catalyze an ATP-depen-
dent adenylation of a carboxylate substrate to its correspond-
ing thiolated form. BomJ shares 36% identity and 46%
similarity with YtkQ, which has been characterized as an
ATP-dependent CoA ligase involved in the activation of the
carboxyl group of the precursor for the subsequent amide
bond formation in the biosynthesis of yatakemycin (Huang
et al., 2012). BomJ may activate 3-HAA similarly to the AMP-
linked intermediate, and then direct nucleophilic attack of the
amino group of one 3-HAA to the acyl group of AMP-linked
3-HAA to afford 7 (Scheme 1C). Gene deletion of bomJ resulted
in the complete loss of the production of 1 in the DbomJ mutant
WDY207. Unexpectedly, a new compound was accumulated in
WDY207 (Figure 3), and its structure was further deduced as 6
(m/z 275.0659 [M + H]+, calculated 275.0663) through HR-
ESIMS and MS/MS analysis (Figure 4). Compound 6 differs
from 1 by consisting of a single 3-HAA unit connected with 3-
HPA via an amide bond. One reasonable explanation for the
production of 6 is that BomK displays substrate promiscuityª2015 Elsevier Ltd All rights reserved 1317
Figure 4. LC-HR-ESIMS Analysis of Com-
pounds 2, 5, 6, 7, and 8
(A) LC-HR-ESIMS/MS analysis of compound 2.
(B) LC-HR-ESIMS analysis of compound 5. 1H-1H
COSY and selected HMBC correlations are
labeled in compound 5.
(C) LC-HR-ESIMS/MS analysis of compound 6.
(D) LC-HR-ESIMS/MS analysis of compound 7.
(E) LC-HR-ESIMS analysis of compound 8.and catalyzes the coupling of free-standing 3-HAA with BomM-
tethered 3-HPA.
Regulatory and Resistance Genes
The deduced product of bomC showed similarity to VmsS (44%
identity), which is a pathway-specific transcriptional regulator in
the virginiamycin biosynthetic pathway (Pulsawat et al., 2007),
suggesting the possibility that BomC might positively regulate
the biosynthesis of 1. BomI resembles TetR family regulators,
which contains a conserved helix-turn-helix DNA-binding
domainpfam00440 (Ramoset al., 2005), implying that this protein
maybea repressive transcriptional regulator.Consistentwith this
speculation, inactivation of natR3, the homologous gene of bomI
(52% identity and 64% similarity) in the nataxazole pathway, led
to 4-fold elevated nataxazole production (Cano-Prieto et al.,
2015). Two putative transporter genes are also present in the
bom cluster. The deduced amino acid sequence of bomG and
bomH are highly similar to that of ATP-binding cassette trans-
porters, which comprise a large and diverse group of proteins
capable of transporting a wide variety of different compounds
at the expense of ATP hydrolysis (Martin et al., 2005). In addition,
BomGandBomHshowhigh similaritywithNatT1 andNatT2 from
the nataxazole biosynthetic pathway (Table S1), respectively,
implying that a similar self-protectionmechanismmay be utilized
by A33853 and nataxazole-producing strains.1318 Chemistry & Biology 22, 1313–1324, October 22, 2015 ª2015 Elsevier Ltd All rights resMutasynthesis of A33853 Analogs
in Mutant Streptomyces sp.
NRRL12068
In an effort to design and develop novel
anti-leishmanial agents, Tipparaju et al.
(2008) synthesized 1 and several of its
derivatives to evaluate their activities
against leishmaniases. Compounds 9
and 10, in which the 3-HPA moiety was
substituted by picolinic acid and 3-fluoro-
picolinic acid, respectively, were thus
found to display anti-leishmanial activity
comparable with that of the first-line
drug miltefosine while showing lower
toxicity. Elucidation of the biosynthetic
pathway of 1 provides us the opportunity
to generate libraries of 10 analogs for
structure-activity relationship studies
and even for the screening of promising
anti-leishmanial drug candidates.
The accumulation of compound 2 in
WDY201, together with the finding that
inactivation of bomK led to the production
of compound 5, implied that BomK couldaccept substrates other than 3-HPA to assemble the analogs of
1. We therefore set out to feed WDY201 with various substrates
structurally similar to 3-HPA. As shown in Figure 6, the feeding
of picolinic acid and 3-fluoropicolinic acid led to the production
of two new compounds in WDY201 with [M + H]+ ions at m/z
376.0922 and m/z 394.0824, respectively. MS/MS analysis of
both ions’ fragments further confirmed that these twocompounds
are 9 and 10, respectively. However, several other substrates
suchaspyrimidine-2-carboxylic acidwerealso tested, but nocor-
responding analogs of 1 were detected in WDY201 (Figure 6),
implying that these substrates may be toxic to the host strain or
that these compounds could not penetrate into the cell, or that
BomL/BomK could not accept these compounds as its sub-
strates. Nevertheless, our findings open a new avenue for the
development of novel pharmaceutical agents against Leishmania.
DISCUSSION
In this study, we have cloned the gene cluster for the biosyn-
thesis of 1, which contains an unusual benzoxazole moiety. Bio-
informatics analysis and functional characterization of the orfs
contained in the gene cluster led us to propose the biosynthetic
pathway of 1 in Streptomyces sp. NRRL12068 as shown in
Scheme 1.erved
Figure 5. In Vitro Characterization of BomL,
BomM, and BomK
(A) A scheme for BomL catalyzed reaction.
(B) HR-ESIMS analysis of holo-BomM in the con-
trol reaction without BomL.
(C) HR-ESIMS analysis of 3-HPA-S-BomM pro-
duced in BomL catalyzed reaction.
(D) LC-HR-ESIMS analysis of products of the
BomK-CFE reactions. (i) Wild-type Streptomyces
sp. NRRL12068; (ii) control assay with 5; (iii)
enzymatic conversion of 5 by BomK-CFE; (iv)
DbomN mutant WDY210; (v) control assay with 7;
(vi) enzymatic conversion of 7 by BomK cell-free.The 3-HPA residue has also been found in several other natural
products including nikkomycin, virginiamycin, viridogrisein, and
pyridomycin (Figure S4). Although the biosynthesis of picolinate,
especially the steps involved in the aromatization of the piperi-
dine ring, has been profoundly studied, little information is avail-
able for the hydroxylation reaction on the picolinic ring. In silico
analysis indicated that the putative FMN reductase BomA and
the putative flavin adenine dinucleotide-dependent oxidoreduc-
tase BomD may constitute a two-component flavin-dependent
monooxygenase system to catalyze the hydroxylation on pico-
linic ring. Such two-component flavin-dependent monooxyge-
nase systems are abundant in the biosynthetic pathways of nat-Chemistry & Biology 22, 1313–1324, October 22, 2015ural products. For instance, ActVB has
been characterized to form a two-compo-
nent oxidation system with ActVA-ORF5
to catalyze the quinone forming at the
C-6 of 6-deoxydihydrokalafungin, and hy-
droxylation at C-8 of dihydrokalafungin in
the biosynthesis of actinorhodin (Oka-
moto et al., 2009; Taguchi et al., 2011,
2013; Valton et al., 2004, 2006). Another
example is the two-component system
composed of SnaA, SnaB, and SnaC, in
which SnaC provides FMNH2 for the con-
version of pristinamycin IIB to pristinamy-
cin IIA catalyzed by the heterodimer of
SnaA and SnaB (Blanc et al., 1995).
Peptide natural products are commonly
assembled by three major strategies. The
first one uses non-ribosomal peptide syn-
thetase (NRPS) assembly lines to activate
and condensate amino acid monomers in
sequential order, as exemplified by the
biosynthesis of vancomycin and dapto-
mycin (Nolan and Walsh, 2009). The sec-
ond employs the ribosomal synthesis ma-
chinery to yield a peptide precursor that
will then undergo various posttransla-
tional modifications and/or proteolysis to
give the final product as exemplified by
Microcin B17, thiopeptides, and the lanti-
biotics (Knerr and van der Donk, 2012;
Nolan and Walsh, 2009; Zhang and Liu,
2013). The third strategy uses a group ofATP-dependent ligases to catalyze the coupling of amino acid
monomers and accounts for the biosynthesis of novobiocin,
coumermycin, and dapdiamide (Hollenhorst et al., 2009;
Schmutz et al., 2003; Steffensky et al., 2000). Also, there are
several uncommon strategies for the amide bond formation,
such as the transglutaminase-like protein AdmF in the biosyn-
thesis of andrimid, a putative class C b-lactamase CapW pair
in the biosynthesis of A-503083s, and the tRNA-dependent ami-
noacyltransferase PacB in the biosynthesis of pacidamycin (Fu-
nabashi et al., 2010; Zhang et al., 2011). Another uncommon
strategy in the natural product biosynthesis for amide bond for-
mation is to use a free-standing substrate as the acceptor toª2015 Elsevier Ltd All rights reserved 1319
Figure 6. Mutasynthesis Performed in
DbomE Mutant WDY201
(A) HPLC analysis of the metabolites of (i) wild-type
Streptomyces sp. NRRL12068; (ii) DbomE mutant
WDY201; (iii) DbomE complementation strain
WDY214; (iv) WDY201 fed with 3-HPA; (v) WDY201
fed with picolinic acid; (vi) WDY201 fed with 3-F
picolinic acid; and (vii) WDY201 fed with pyrimi-
dine-2-carboxylic acid.
(B and C) LC-HR-ESIMS/MS analysis of com-
pounds 9 (B) and 10 (C).couple with a carrier protein-tethered acyl donor. One particular
example can be found in the biosynthesis of vibriobactin
whereby VibH, a free-standing C domain, was found to catalyze
the formation of an amide bond (Keating et al., 2002). However,
bioinformatics analysis of the bom cluster revealed none of the
above amide synthase homologs. Instead, our study discovered
an unprecedented case whereby the ketosynthase-like BomK
catalyzes the amide bond formation in 1’s pathway. Our data
have shown that BomK could catalyze the transfer of BomM-
tethered 3-HPA to the amino group of compounds 5 and 7. In
addition, the phylogenetic tree analysis of BomK and other keto-
synthases revealed that it positions with ChlB3 and CerJ in the
close clades (Figure S5), which implies that BomK functions
like an acyl transferase (Bretschneider et al., 2012; He et al.,
2009). Thus, this is the first report that a ketosynthase-like
enzyme catalyzes the amide bond formation. It is highly likely
that BomK also displays broad substrate tolerance and has the
ability to convert BomM-tethered 3-HPA and free-standing
3-HAA into 6 (Scheme 1C).
We also deduced the function of BomJ as an amide bond syn-
thetase that is responsible for the coupling of two units of 3-HAA.
Sequence alignment of BomJ in GenBank showed that it
belongs to the AFD superfamily by containing a conserved
AMP-binding motif (SSGSAGQP). Enzymes in this superfamily
generally activate a carboxylate substrate as an adenylate and
then transfer the AMP-linked substrate to the pantetheine group
of either CoA or acyl-carrier protein. We thus speculate that the1320 Chemistry & Biology 22, 1313–1324, October 22, 2015 ª2015 Elsevier Ltd All rights resproposed amide bond condensation ac-
tivity of BomJ would resemble the catal-
ysis performed by common CoA ligases,
except that an amino group is used as
the nucleophilic donor. A similar strategy
has been proposed in the diazepinomicin
pathway for amide bond formation cata-
lyzed by a putative coenzyme F390 syn-
thetase orf24 (Bonitz et al., 2013). The
in vitro biochemical characterization of
BomJ, as well as genome mining of
gene homologs of bomK/bomJ in other
putative natural product biosynthetic
gene clusters, which are currently under
way in our laboratory, could shed light
on understanding the novel enzymatic
mechanisms for amide bond formation
and discovering new a family of amide
bond-containing natural products.The structure of the oxazole heterocycle is unique in peptide
natural products. Two enzymatic strategies have been evolved
by nature to construct oxazole, one of which is directed by
NRPS containing the Cy domain with the other being operated
by the YcaO family of proteins (Melby et al., 2011). However,
there is no homolog of these classic oxazole synthases found
in the bom cluster. Unexpectedly, our results indicate that
BomN, a putative amidohydrolase, is possibly responsible for
the oxazole ring closure reaction, since two compounds lacking
an oxazole ring were accumulated in DbomNmutant strain (Fig-
ures 3 and 4). The BomN-catalyzed reaction may thus represent
the third enzymatic strategy to construct oxazole in nature. It is
interesting to note that calcimycin also contains the same ben-
zoxazole moiety, whose biosynthesis is still enigmatic (Wu
et al., 2011). However, there is no homologous gene of bomN
contained in the cal gene cluster, implying that diverse mecha-
nisms directing the formation of benzoxazole exist.
Recently, Olano and coworkers proposed a model for the
biosynthesis of nataxazole in Streptomyces sp. Tϋ6176 (Cano-
Prieto et al., 2015). They speculated that all the building blocks,
including 6-MSA and 3-HAA, were connected with each other via
two amide bonds in the form of ACP (NatAC1 and NatAC2)-teth-
ered intermediates during the biosynthesis of nataxazole. How-
ever, the enzymes responsible for the formation of the amide
bonds and the benzoxazole were not identified. Nataxazole
and 1 are very close in structure, implying that they share similar
logic in skeleton assembly. In this work, we have determined theerved
enzyme (BomK) that is involved in amide bond formation be-
tween 3-HPA and 3-HAA via both in vivo and in vitro experi-
ments, and proposed the functions of two other enzymes
(BomJ and BomN) that may be responsible for the benzoxazole
formation according to the gene knockout results. Our study
thus provides further insights into the logic underlying the
biosynthesis of natural products in the benzoxazole family.
SIGNIFICANCE
Antibiotic A33853 is a promising scaffold lead for the devel-
opment of novel anti-leishmanial drugs. It contains an
unusual benzoxazole moiety under which the formation
mechanism is still enigmatic. In this work, we have identified
and functionally characterized the individual genes involved
in the biosynthesis of A33853. Our findings not only suggest
an interesting logic underlying the skeleton assembly of
A33853 in which an unusual ketosynthase-like enzyme
BomK is involved in the amide bond formation between 3-
HPA and 3-HAA, but also provide clues to understanding
how benzoxazole is formed during the biosynthesis of
such groups of natural products. In addition, the successful
generation of two analogs of A33853 paves the way for
further engineering of the discovered biosynthetic machin-
ery to create new drug leads for anti-leishmanial agents.
EXPERIMENTAL PROCEDURES
Media and Strains
E. coliDH10B and E. coli ET12567 (pUZ8002) were cultured in L Broth or L agar
at 37C. Streptomyces albus J1074, Streptomyces sp. NRRL12068, and its
related mutant were cultured on MS medium (20 g/l mannitol, 20 g/l soybean
meal, 20 g/l agar, pH 7.2) for spores formation, in TSBY medium (5 g/l yeast
extract, 30 g/l tryptone soya broth) for mycelium and seeds culture, and in
AY medium (70 g/l dextrin, 10 g/l BD peptone, 4 g/l MgSO4d7H2O, 5 g/l
oatmeal, 5 g/l CaCO3) for fermentation. MS medium containing the final con-
centration of 30 mM Mg2+ was used for conjugation of S. albus and Strepto-
myces sp. NRRL12068.
DNA Sequencing and Analysis
Streptomyces sp. NRRL12068 genomic DNA was prepared through the
salting-out method, and sequenced by Illumina Hiseq 2000 with a 300-bp
paired-end library by the TruSeq method. A total of 4,143,748 paired-reads
were obtained and assembled by SOAP de novo software (http://soap.
genomics.org.cn/soapdenovo.html) with the parameters ‘‘sequence length
>25 bp and base quality >20.’’ When the K-mer was 21, the best assembly
result could be obtained. The resultant 165 scaffolds were further annotated
by RAST (http://rast.nmpdr.org/rast.cgi) and further analysis via antiSMASH
(http://antismash.secondarymetabolites.org). The A33853 biosynthetic gene
cluster was identified from the sequenced genome via silica analysis, and
was submitted to NCBI GenBank with the accession number GenBank:
KR476659.
The ORFs were deduced from the sequence using the FramePlot 4.0 beta
program (http://nocardia.nih.go.jp/fp4/). The corresponding deduced proteins
were compared with other known proteins in the databases using BLAST
(http://www.ncbi.nlm.nih.gov/blast/). Amino acid sequence alignments were
performed with the CLUSTALW algorithm from BIOLOGYWORKBENCH 3.2
software (http://workbench.sdsc.edu).
Genomic Library Construction and Screening
A genomic library of Streptomyces sp. NRRL12068 was constructed using a
Copy Control Fosmids Library Production Kit (Epicentre Biotechnologies
Cat. No. CCFOS110) according to the manufacturer’s instructions, except
that the vector used was EcoRV-digested pJTU2554 instead of pCC1Fos.Chemistry & Biology 22, 1313–1The primers (Primer-oxo-F/Primer-oxo-R, Primer-dam-F/Primer-dam-R, and
Primer-pfa-F/Primer-pfa-F R) were used for PCR-based screening of the
genomic library. Cosmid 8D3 was thus identified to contain the putative
A33853 biosynthetic gene cluster.
Construction of WDY201 to WDY213
To inactivate bomE, a 2,245-bp upstream fragment and a 2,241-bp down-
stream fragment were amplified from cosmid 8D3 by PCR using the primers
bomE-Left-F/bomE-Left-R and bomE-Right-F/bomE-Right-R, respectively.
PCR was performed in 30 ml of volume with 5% DMSO and KOD DNA poly-
merase (Toyobo). The obtained fragments were digested with XbaI/BamHI
and BamHI/EcoRI, respectively, and cloned into the XbaI/EcoRI site of
pKC1139 to give the in-frame deletion construct pWDY201, which was then
transferred into Streptomyces sp. NRRL12068 via E. coli-Streptomyces
conjugation. Following the procedure described previously (Yu et al., 2009),
the bomE in-frame deletion mutant strain was screened out and designated
as WDY201. The same strategy was employed to construct WDY202 to
WDY213, in which orf2, bomB, bomC, bomD, bomJ, bomK, bomL, bomN,
bomO, bomR, and orf3 were in-frame deleted from Streptomyces sp.
NRRL12068, respectively.
Complementation of Gene Knockout Strains
To complement bomE knockout strainWDY201, a 1,294-bp fragment contain-
ing the whole bomE gene sequence was amplified by high-fidelity PCR using
primers HB-bomE-F/HB-bomE-R. The obtained fragment was then cloned
into the NdeI/EcoRI site of pIB139, which can integrate into attB site in Strep-
tomyces chromosome, to generate the construct pWDY214. It was then
transferred into WDY201 via E. coli-Streptomyces conjugation. Following the
procedure described above, the DbomE complementation mutant strain was
screened out and designated as WDY214. The same strategy was employed
to construct WDY215 to WDY218, in which gene deletion of bomO, bomB,
bomC, and bomK was complemented, respectively.
Cultivation, Fermentation, and LC-HRMS Analysis
Streptomyces sp. NRRL12068 and its related mutant strains were inoculated
into TSBY medium and grown for 36 hr at 28C at 220 rpm, then transferred
into AY fermentation medium for continuous cultivation at 28C and
220 rpm for 7 days. The culture was then centrifuged and the supernatants
collected, which were further extracted by an equal volume of ethyl acetate.
The organic phase was collected and evaporated to dryness. Residues
were redissolved in 1/100 of original culture volume of methanol for HPLC
or LC-MS detection. The HPLC analyses were carried out on a DIONEX sys-
tem equipped with a P680 HPLC pump using a DIKMA Diamonsil C18 column
(5 mm, 2503 4.6 mm) eluted with a linear gradient from 60:40 A/B to 15:85 A/B
over 15 min after balanced 5 min with 60:40 A/B at a flow rate of 0.8 ml/min
(solvent A was 0.1% formic acid in H2O and solvent B was 0.1% formic
acid in CH3CN). UV was monitored at 254 nm. The identities of A33853 and
its analogs were characterized by high-resolution MS (HRMS) analysis, which
consists of a full scan in positive mode followed by a data-dependent frag-
mentation scan, through a Thermo Scientific LTQ XL Orbitrap mass spectrom-
eter equipped with a Thermo Scientific Accela 600 pump (Thermo Fisher
Scientific). The following parameters were set: capillary voltage 45 V, capillary
temperature 45C, auxiliary gas flow rate 10 arbitrary units (a.u.), sheath gas
flow rate 40 a.u., spray voltage 3.5 kV, and mass range 100–2000 amu
(maximum resolution 30,000).
Mutasynthesis of Analogs of A33853 in Streptomyces sp.
NRRL12068
For the mutasynthesis of analogs of A33853, 5ml seed culture ofWDY201was
inoculated into 50 ml AY fermentation broth after being grown at 28C and
220 rpm for 36 hr. The final concentration of 100 mg/ml 3-HPA, picolinic
acid, 3-F picolinic acid, or pyrazine-2-carboxylic acid was fed separately
into the cultures when seed culture was transferred into the fermentation me-
dium. After cultivation at 28C and 220 rpm for 7 days, the fermentation culture
was finally centrifuged, and the supernatants were collected and extracted by
an equal volume of ethyl acetate. After evaporation of the solvent, the residues
were dissolved inmethanol and further analyzed using HPLC or LC-HR-ESIMS
as mentioned above.324, October 22, 2015 ª2015 Elsevier Ltd All rights reserved 1321
Isolation of Compounds 5 and 7 and Determination of Their
Structures
For the isolation of the accumulated compound 5 in WDY208 and com-
pound 7 in WDY210, the crude extract of 4 l of WDY208 and 10 l of
WDY210 fermentation liquor was separately passed through macroporous
adsorptive resins, which was eluted with 30% methanol and 80% methanol.
The fraction of 80% methanol was then concentrated and loaded onto a
size-exclusion column packed with Sephadex LH20 (GE Healthcare) with
methanol as the solvent, and fractions containing the purified target com-
pound were collected. The purified compound 5 was resolved in CD3OD
and compound 7 in DMSO-d6, and both of them were characterized using
NMR.
The NMR data were recorded on a Bruker Avance 500-MHz NMR
spectrometer.
Compound 5: 1H-NMR, dH (500 MHz, CD3OD), 9.49 (1H, d, 7.84, H-3), 8.96
(1H, t, 7.89, H-4), 9.34 (1H, d, 8.10, H-5), 9.07 (1H, d, 8.18, H-12), 8.37 (1H, d,
7.54, H-14), 8.15 (1H, t, 7.87, H-13). 13C-NMR, dC (150 MHz, CD3OD), 170.17
(C, C-1), 124.88 (C, C-2), 128.05 (CH, C-3), 125.58 (CH, C-4), 115.37 (CH, C-5),
151.73 (C, C-6), 143.15 (C,C-7), 146.77 (C, C-8), 109.46 (C, C-9), 140.48 (C,
C-10), 166.58 (C, C-11), 120.69 (CH, C-12), 177.66 (CH, C-13), 177.64 (CH,
C-14).
Compound 7: 1H-NMR, dH (500 MHz, DMSO-d6), 7.51 (1H, dd, 7.52, 1.61,
H-3), 7.04 (1H, t, 7.76, H-4), 6.95 (1H, dd, 7.93, 1.65, H-5), 7.35 (1H, dd,
8.16, 1.23, H-12), 6.46 (1H, d, 7.87, H-13), 6.84 (1H, dd, 7.65, 1.28, H-14).
13C-NMR, dC (150 MHz, DMSO-d6), 172.34 (C, C-1), 131.33 (C, C-2), 124.80
(CH, C-3), 127.23 (CH, C-4), 123.10 (CH, C-5), 151.98 (C, C-6), 130.73
(C,C-7), 147.66 (C, C-8), 116.43 (C, C-9), 142.56 (C, C-10), 171.57 (C, C-11),
121.88 (CH, C-12), 117.39 (CH, C-13), 118.63 (CH, C-14).
Construction of BomE, BomL, and BomM Overexpression Plasmids
The genes bomE, bomL, and bomM were separately amplified by high-fidelity
PCR from cosmid 8D3 using primers pET28a-BomE-F/pET28a-BomE-R,
pET28a-BomL-F/pET28a-BomL-R, and pET28a-BomM-F/pET28a-BomM-R.
The PCR products were then cleaved by NdeI and XhoI and cloned into the
NdeI/XhoI sites of pET28a to generate expression vectors pWDY205,
pWDY224, and pWDY225.
Construction of the pHS_SUMO Expression Vector
A 291-bp fragment which contains the whole SUMO was amplified from
genomic DNA of Saccharomyces cerevisiae by PCR using the primers SU-
MO_F/SUMO_R. PCR was performed in 20 ml of volume with 5% DMSO and
KOD DNA polymerase (Toyobo). The amplification conditions were: initial
denaturation at 95C for 5 min; 30 cycles of denaturation at 95C for 30 s; an-
nealing at 58C for 30 s and extension at 68C for 30 s; and gap infilling at 68C
for 10 min. The obtained fragments were cloned into the NdeI/SacI sites of
pET28a+ (Novagen) using an In-fusion HD Cloning Kit (Clontech) to yield the
protein overexpression vector pHS_SUMO.
Construction of BomK Overexpression Vector
To overexpress BomK, a 1,080-bp fragment which contains the whole bomK
was amplified from cosmid 8D3 by PCR using the primers sumo-BomK-F/R.
The products were cloned into the KpnI/XhoI sites of pHS_SUMO using an
In-fusion HD Cloning Kit (Clontech) to yield the overexpression construct
pWDY227, which was then transformed into E. coli BL21 (DE3) (Novagen) to
generate WDY227.
Overexpression and Purification of BomE, BomL, and BomM
E. coli BL21 (DE3) cells containing pWDY205 were grown in 500 ml of super
optimal broth medium supplemented with 50 mg/ml kanamycin at 37C with
shaking at 250 rpm until an A600 of 0.3–0.5 was reached. Protein expression
was induced by addition of 0.5 mM isopropyl b-D-1-thiogalactopyranoside
with further cultivation at 28C for 4 hr. The cells were then harvested by
centrifugation and frozen at 80C. For purification of the His6-tagged
BomE protein, the cell pellet was resuspended in 40 ml of ice-cold lysis
buffer (50 mM potassium phosphate, 200 mM KCl, 5 mM imidazole, pH
8.0), and disrupted by a Nano Homogenize Machine (ATS Engineering,
AH100B). To separate the cellular debris from the soluble protein, the lysate
was centrifuged at 12,000 rpm and 4C for 30 min. 1 ml of Ni-nitrilotriacetic1322 Chemistry & Biology 22, 1313–1324, October 22, 2015 ª2015 Eacid resin slurry (GE Healthcare) was then added to the supernatant frac-
tion, which was contained in a small ice box, and gently stirred for 1 hr.
The mixture was transferred to a disposable column and washed with
5 ml of wash buffer (50 mM potassium phosphate, 200 mM KCl, 50 mM
imidazole, pH 8.0). Recombinant BomE was eluted with 5 ml of elution
buffer with 300 mM imidazole. The eluted fractions were concentrated to
2.5 ml using Centrifugal Filter Units (Millipore, Regenerated Cellulose
10,000 MWCO). The protein sample was then desalted by PD-10 Columns
(GE Healthcare) according to the manufacturer’s instructions. The same
procedure was used to purify BomL and BomM, except that BomM was
overexpressed in E. coli BAP1 strain which contains an sfp gene (Pfeifer
et al., 2001). BomE was stored in storage buffer (50 mM potassium phos-
phate, 100 mM KCl, 10% [w/v] glycerol, pH 8.0) at 80C. BomL was
stored in storage buffer (50 mM Tris-HCl, 100 mM NaCl, 10% [w/v] glycerol,
pH 8.0).
Enzyme Assay of BomE
Lysine 2-aminotransferase activity was determined based on the method
described previously (Soda et al., 1968). Enzyme assay of BomE activity
was carried out in a 100-ml scale with 5 mM L/D-lysine, 100 mM 2-ketoglu-
tarate, 70 mM pyridoxal phosphate, and 10 mM purified enzyme in 50 mM
MOPS buffer (pH 7.2). The mixture was incubated at 30C for 25 min. The
reaction was terminated by addition of 50 ml 100% (w/v) trichloroacetic
acid. Proteins were removed by centrifugation. 40 ml of the supernatant
was added into 40 ml of mixture containing 40 mM o-aminobenzaldehyde,
200 mM potassium phosphate (pH 8.0) of absolute methanol. A yellow-
orange dihydrochinazolinium complex was developed during incubation at
37C for 2 hr. The detection of the substrate and product were analyzed
by HPLC, which was carried out on a DIONEX system equipped with P680
HPLC pump, using a DIKMA Diamonsil C18 column (5 mm, 250 3 4.6 mm)
eluted with a linear gradient from 5% B to 95% B for 5–20 min, at a flow
rate of 0.5 ml/min (solvent A was H2O and solvent B was CH3CN), UV moni-
tored at 450 nm. The HR-ESIMS analysis of the reactions was performed as
mentioned above.
Enzyme Assay of BomL
The reaction (100 ml) contained 50 mM Tris-HCl (pH 8.0), 10 mM MgCl2,
2 mM DTT, 5 mM ATP, 2 mM substrate, 2 mM BomL, and 10 mM holo-
BomM. Reactions were initiated by the addition of BomL, followed by incu-
bating at 37C for 20 min, then quenched by flash-freezing at 80C. The
clarified supernatant was analyzed by HPLC-HR-ESIMS (resolution
100,000), which was carried out on a Hypersil GOLD C4 column (Thermo Sci-
entific). The column was equilibrated for 5 min with 95% solvent A (H2O,
0.1% formic acid) and 5% solvent B (CH3CN, 0.1% formic acid) and eluted
with a linear gradient from 95% A/5% B to 5% A/95% B, for 5–20 min at a
flow rate of 0.2 ml/min.
Biochemical Analysis of BomK in the Cell-Free System
Approximately 1.2 g of WDY227 overexpression cultures were extracted with
1ml of buffer containing 50mMTris-HCl (pH 8.0) and 50mMNaCl. Themixture
was filtrated to provide the crude enzyme. For the cell-free conversion, 50 ml of
crude enzyme was added into 100 ml of BomL reaction system, incubated at
37C with 5 mM compound 5 or 7 as substrate for 1.5 hr, using the wild-
type E. coli BL21 (DE3) extracts as control. The reactions were quenched by
adding equal volumes of methanol. The reaction products were analyzed
with HPLC-HR-ESIMS as described above.
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